Status:
ACTIVE_NOT_RECRUITING
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
Lead Sponsor:
Centre for Endocrinology and Reproductive Medicine, Italy
Conditions:
Uterine Adenomyosis
Recurrent Implantation Failure
Eligibility:
FEMALE
30-45 years
Phase:
PHASE4
Brief Summary
With this study the investigators want to test which is the best medical treatment for symptomatic adenomyosis affecting women undergoing IVF and with previous implantation failure, between Aromatase ...
Detailed Description
Recently it has been shown that adenomyosis negatively affects the pregnancy rate in IVF cycles. The investigators used in the past for the treatment of other benign gynecological diseases such as end...
Eligibility Criteria
Inclusion
- women with healty conditions
- Adenomyosis
- increased uterine dimensions
- recurrent implantation failure
Exclusion
- presence of systemic diseases
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03421639
Start Date
December 1 2017
End Date
September 30 2024
Last Update
March 6 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Spitali Amerikan
Tirana, Albania
2
Nadezda Women's Health Hospital
Sofia, Bulgaria
3
Cerm-Hungaria
Rome, Italy, 00153